| Companies sponsors |
Servier Laboratories (ivosidenib) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Blood Cancer UK |
| |
Leukaemia Care |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Comparator companies |
AbbVie (venetoclax) (confidentiality agreement signed, participating) |
| |
Accord Healthcare (azacitidine, cytarabine) (confidentiality agreement not signed, not participating) |
| |
Bristol Myers Squibb (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Celgene (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories (UK) (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (cytarabine) (confidentiality agreement not signed, not participating) |
| |
Jazz Pharmaceuticals (cytarabine) (confidentiality agreement signed, participating) |
| |
Mylan (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Pfizer (cytarabine) (confidentiality agreement not signed, not participating) |
| |
Sandoz (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Seacross Pharmaceuticals (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Tillomed (azacitidine) (confidentiality agreement not signed, not participating) |
| |
Zentiva (azacitidine) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |